| Year | Federal $ expended | Auditor | Opinion | Flags |
|---|---|---|---|---|
| 2025 | $25.5M | Clark Nuber PS | Unmodified (clean) | Low-risk auditee |
| 2024 | $30.5M | Clark Nuber PS | Unmodified (clean) | Low-risk auditee |
| 2023 | $32.4M | Clark Nuber P.S. | Unmodified (clean) | Low-risk auditee |
| 2022 | $26.0M | Clark Nuber P.s. | Unmodified (clean) | Low-risk auditee |
| Program | Agency | Expended | Major program | Findings |
|---|---|---|---|---|
| Allergy and Infectious Diseases Research | HHS | $3.7M | Yes | 0 |
| Cancer Centers Support Grants | HHS | $2.9M | Yes | 0 |
| LUNG Diseases Research via NYU Grossman School of Medicine | HHS | $2.6M | Yes | 0 |
| Cancer Detection and Diagnosis Research | HHS | $1.8M | Yes | 0 |
| Human Genome Research | HHS | $1.7M | Yes | 0 |
| National Center for Advancing Translational Sciences via Penn State University | HHS | $1.2M | Yes | 0 |
| Biological Sciences | NSF | $1.2M | Yes | 0 |
| Experimental Design, Implementation via Lawrence Berkeley National Lab | Energy | $1.2M | Yes | 0 |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | HHS | $1.1M | Yes | 0 |
| Cancer Genomics Cloud Reource via Leidos Biomedical Research, Inc. | HHS | $932K | Yes | 0 |